Improving life for women through cancer research

Click on the image to listen to Associate Professor Alison Brand, ANZGOG Chair and Ms Cheryl Waller, ovarian cancer survivor speak about Clinical Trials.
 
What is a clinical trial_ANZGOG
 
 
Stages of a Clinical Trial
Download as a PDF click here

Phase I – Phase I clinical trials involve administration of the research treatment into healthy human participants for the first time. These trials are conducted in a small number of healthy participants to gather information about the safety and potential side-effects the research treatment may cause in the human body. The participants are carefully monitored for the duration of the entire trial.
 
Phase II – Phase II clinical trials are conducted with a group of participants who have been diagnosed with the disease the treatment was intended for. During a Phase II trial, information is gathered about the safety and effectiveness of the research treatment in these patients.
 
Phase III – Phase III clinical trials are conducted in a larger group of patients to compare the research treatment with the standard treatment or *placebo treatment. These trials are used to gather large amounts of information about how the research treatment treats the disease compared to the standard treatment. Governments and other authorities will use this information to decide whether the risks and benefits of the new treatment justify it becoming available to the public.
 
*Placebo treatment– participants are given an inactive form of the treatment. A placebo is used to test whether the effects being seen in the trial is really due to the treatment itself or just because the participant “thinks” that they are being treated. The human mind is very powerful so the research team must be sure that the treatment is effective and not due to the power of positive thinking.
 
Treatment Registration – Once a treatment has successfully completed a Phase III clinical trial, the sponsor is able to register the treatment with the appropriate governments. After the treatment is registered, it will become available to the public.
 
Phase IV – Phase IV trials are conducted after the treatment has become available to the public. These trials are conducted to gather information about the safety and effectiveness of the treatment over a long period of time. Information is also gathered to investigate if the treatment can be used in other circumstances.
 
All clinical trials are conducted by an Investigator (doctor) and their research team, consisting of Research Nurses, Study Coordinators, Pharmacists and other health care professionals.
 
What is Gynaecological Cancer Research About?
 
All new treatments have to be scientifically proven before becoming available to the general public.  This includes early detection tests for gynaecological cancers.
 
Trials are designed to:
Identify the best possible treatment for a gynaecological cancer;
or
Demonstrate a better/different way to use the existing treatment for a gynaecological cancer;
or
Measure improvements in the quality of life of gynaecological cancer patients, after certain treatment;
or
Obtain scientific information about prevention and early detection of gynaecological malignancies.
 
Clinical trials have been the catalyst for new treatments of gynaecological cancer patients.  They identify the best therapies and treatment procedures.
 
 
Are ANZGOG Clinical Trials Safe?
 
ANZGOG gynaecological clinical trials undergo a rigorous review process before becoming active.  This ensures the reliability of the research and the safety of the patient.
 
Every clinical trial has its own Protocol.  The Protocol outlines the course of action required to answer the intended research question.
 
The Protocol identifies:
The type of trial participants
Al procedures and interventions
Test schedules
Medications and dosages
Study length
Follow-up processes
Data collection
Analysis processes
 
The Protocol is designed to safeguard the health of the participants. Every institution participating in the clinical trial uses the same Protocol.

The clinical trial Protocol is meticulously scrutinized and reviewed by the ANZGOG Research Advisory Committee, the Ethics Committee of the University of Sydney and the Ethics Committees at each of the institutions that participate in the trial.
 
An Ethics Committee consists of a panel of scientists, medical professionals and laypersons, who undertake to ensure the ethical and scientific integrity of the trial.
 
A Protocol could be amended numerous times before all relevant ethics approvals are received. It is only once the Protocol passes all ethics approvals that the gynaecological cancer clinical trial is opened for recruitment.
 
Once the trial is active, a Trial Management Committee closely monitors the research sites involved to certify compliance with the trial Protocol. 
 
To maintain patient safety throughout the trial, patients are closely monitored to make certain any unexpected side effects are detected and treated promptly.
 
All ANZGOG trials are regularly audited for quality control by independent researchers.
 
 
What is Informed Consent?

The patient’s “informed consent” is required to participate in a clinical trial.  
 
This means the patient agrees they fully understand what is expected of them, including potential benefits and risks, before they decide to participate in the trial.
 
The Patient Informed Consent Form (PIC) documents the necessary information for patients to be completely informed about a particular clinical trial. 
 
A PIC details:
The research question
The intervention method
Possible risks and benefits
Tests to undertake
Expected length of the trial
Any out of pocket expenses
 
If you are considering participating in a clinical trial, your physician will give you the PIC to review at home with family.  You will have to sign the PIC before participating in the trial.  The clinical trial team can answer any questions you may have regarding this document. 

It is a legal requirement for patients to have full disclosure on the gynaecological cancer clinical trial they are considering. Patients have the right to full disclosure of the study status and results at all times.
 
 
Benefits of Participating in a Clinical Trial
 
There are many potential benefits for a patient who participates in an ANZGOG clinical trial including:
 
Having the opportunity to receive a new and possibly more effective treatment than what is currently considered to be the best standard therapy.
 
Potentially improving the success of your own treatment, and at the same time knowing that the findings may change the way women with similar cancers are treated in the future.
 
Receiving very detailed written information about all treatments and their potential benefits, as well as their side effects. As a general rule, patients on clinical trials receive far more information than patients who don’t participate in clinical trials.
 
Being looked after by a clinical trial team including your own doctor, as well as a team of clinical trials nurses and data managers, who will also be closely monitoring your treatment and any side effects.
 
Knowing that the trial and the treatments are being regularly reviewed by the ANZGOG research team and that there are strict requirements for following the treatment protocol.
 
 
How to Participate in an ANZGOG Clinical Trial

All ANZGOG clinical trials open to recruiting patients are listed on our website. This includes the trial Information and the list of institutions enrolling patients.  Ask your physician to help you enrol in an ANZGOG trial that will suit your diagnosis. 
 
ANZGOG Current Trials - click here
 

If your physician or hospital is not registered to run an ANZGOG clinical trial, you can contact the Trial Coordinator at the NHMRC Clinical Trials Centre, listed under the trial details.  The coordinator will be able to provide further information.
 
For information on most clinical trials conducted in Australia and New Zealand, go to the following website: http://www.anzctr.org.au/
 

Back to top